ANI Pharmaceuticals is building a leading Rare Disease company focused on Serving Patients, Improving Lives

RECENT NEWS

ANI Pharmaceuticals to Present at September Investor Conferences

2026-09-03

READ MORE >

ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors 

2026-08-24

READ MORE >

NASDAQ - ANIP

$73.59

+ 1.48 (2.05%)

Pricing delayed by 20 minutes
Last updated 2026-09-16 16:00:00